RTN2

Chr 19ARAD

reticulon 2

Also known as: HMNR11, NSP2, NSPL1, NSPLI, SPG12

This gene belongs to the family of reticulon encoding genes. Reticulons are associated with the endoplasmic reticulum, and are involved in neuroendocrine secretion or in membrane trafficking in neuroendocrine cells. Reticulon proteins also play an important role in the replication of positive-strand RNA (ssRNA) viruses. Mutations at this locus have been associated with autosomal dominant spastic paraplegia-12. [provided by RefSeq, Aug 2020]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismAR/ADLOEUF 0.422 OMIM phenotypes
Clinical SummaryRTN2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.22) despite low pLI — interpret in context.
📋
ClinVar Variants
16 unique Pathogenic / Likely Pathogenic· 179 VUS of 356 total submissions
📖
GeneReview available — RTN2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.42LOEUF
pLI 0.416
Z-score 4.05
OE 0.22 (0.130.42)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
0.70Z-score
OE missense 0.89 (0.810.98)
306 obs / 342.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.22 (0.130.42)
00.351.4
Missense OE?0.89 (0.810.98)
00.61.4
Synonymous OE?0.93
01.21.6
LoF obs/exp: 7 / 31.5Missense obs/exp: 306 / 342.5Syn Z: 0.72

This gene — mechanism propensity

DN
0.5770th %ile
GOF
0.7029th %ile
LOF
0.4430th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF1 literature citation · 94% of P/LP variants are LoF · LOEUF 0.42
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

LOFPatient 11 has a heterozygous frameshift variant in RTN2. As two of the three SPG12-causing variants in this gene described to date are null variants, haploinsufficiency of RTN2 seems to cause SPG12.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 27165006

ClinVar Variant Classifications

356 submitted variants in ClinVar

Classification Summary

Pathogenic8
Likely Pathogenic8
VUS179
Likely Benign106
Benign28
Conflicting22
8
Pathogenic
8
Likely Pathogenic
179
VUS
106
Likely Benign
28
Benign
22
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
7
0
1
0
8
Likely Pathogenic
8
0
0
0
8
VUS
6
158
11
4
179
Likely Benign
0
17
29
60
106
Benign
0
0
20
8
28
Conflicting
22
Total211756172351

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

8 pathogenic / likely-pathogenic (of 13) ClinVar copy-number / structural variants overlap RTN2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

RTN2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →